Independent variables . | Odds ratio (95% CI) . |
---|---|
Variable of interest | |
Diabetes medication nonadherence | |
MPR <80% in 2000 | 2.53 (1.38–4.64)† |
Covariates | |
Age (years) | |
18–44 | 0.27 (0.09–0.82)‡ |
45–54 | 0.53 (0.22–1.26) |
55–64 | 0.35 (0.15–0.84)‡ |
≥65 | 1.00 |
Sex | |
Male | 0.59 (0.33–1.06) |
Female | 1.00 |
Oral antihyperglycemic medications | |
Multiple-drug therapy (2000) | 1.23 (0.69–2.20) |
Single-drug therapy (2000) | 1.00 |
Antihypertensive use pattern | |
None prescribed | 1.00 |
Prescribed (nonadherent) | 0.66 (0.25–1.71) |
Prescribed (adherent) | 0.68 (0.35–1.32) |
Lipid-modifier use pattern | |
None prescribed | 1.00 |
Prescribed (nonadherent) | 0.78 (0.30–2.01) |
Prescribed (adherent) | 1.54 (0.79–3.03) |
Charlson comorbidity index | |
1 | 1.00 |
2–3 | 4.04 (2.54–6.86)† |
≥4 | 16.86 (7.69–36.98)† |
Prior hospitalization (2000) | |
Yes | 1.27 (0.61–2.67) |
No | 1.00 |
Independent variables . | Odds ratio (95% CI) . |
---|---|
Variable of interest | |
Diabetes medication nonadherence | |
MPR <80% in 2000 | 2.53 (1.38–4.64)† |
Covariates | |
Age (years) | |
18–44 | 0.27 (0.09–0.82)‡ |
45–54 | 0.53 (0.22–1.26) |
55–64 | 0.35 (0.15–0.84)‡ |
≥65 | 1.00 |
Sex | |
Male | 0.59 (0.33–1.06) |
Female | 1.00 |
Oral antihyperglycemic medications | |
Multiple-drug therapy (2000) | 1.23 (0.69–2.20) |
Single-drug therapy (2000) | 1.00 |
Antihypertensive use pattern | |
None prescribed | 1.00 |
Prescribed (nonadherent) | 0.66 (0.25–1.71) |
Prescribed (adherent) | 0.68 (0.35–1.32) |
Lipid-modifier use pattern | |
None prescribed | 1.00 |
Prescribed (nonadherent) | 0.78 (0.30–2.01) |
Prescribed (adherent) | 1.54 (0.79–3.03) |
Charlson comorbidity index | |
1 | 1.00 |
2–3 | 4.04 (2.54–6.86)† |
≥4 | 16.86 (7.69–36.98)† |
Prior hospitalization (2000) | |
Yes | 1.27 (0.61–2.67) |
No | 1.00 |
Hospitalizations are limited to those with a primary diagnosis of diabetes or cardiovascular disease;
P ≤ 0.01;
P ≤ 0.05.